A.E. Takemori

12.4k total citations · 1 hit paper
223 papers, 10.3k citations indexed

About

A.E. Takemori is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, A.E. Takemori has authored 223 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Cellular and Molecular Neuroscience, 153 papers in Molecular Biology and 78 papers in Physiology. Recurrent topics in A.E. Takemori's work include Neuropeptides and Animal Physiology (135 papers), Pharmacological Receptor Mechanisms and Effects (111 papers) and Receptor Mechanisms and Signaling (68 papers). A.E. Takemori is often cited by papers focused on Neuropeptides and Animal Physiology (135 papers), Pharmacological Receptor Mechanisms and Effects (111 papers) and Receptor Mechanisms and Signaling (68 papers). A.E. Takemori collaborates with scholars based in United States, China and Thailand. A.E. Takemori's co-authors include Philip S. Portoghese, Marjia Sultana, P. S. Portoghese, Susan J. Ward, Dennis L. Larson, A. W. Lipkowski, Hiroshi Nagase, Mehmet Sofuoglu, F. Cankat Tulunay and Begonia Y. Ho and has published in prestigious journals such as Science, Journal of Biological Chemistry and Annual Review of Biochemistry.

In The Last Decade

A.E. Takemori

222 papers receiving 10.0k citations

Hit Papers

Naltrindole, a highly selective and potent non-peptide δ ... 1988 2026 2000 2013 1988 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.E. Takemori United States 52 8.2k 7.0k 3.6k 516 475 223 10.3k
Norton H. Neff United States 58 6.5k 0.8× 4.9k 0.7× 1.9k 0.5× 243 0.5× 815 1.7× 231 10.9k
Kenneth P. Minneman United States 49 4.7k 0.6× 6.4k 0.9× 2.0k 0.5× 141 0.3× 451 0.9× 141 9.3k
Derek N. Middlemiss United Kingdom 53 7.5k 0.9× 5.6k 0.8× 1.3k 0.4× 221 0.4× 947 2.0× 137 10.7k
L L Iversen United Kingdom 32 5.1k 0.6× 3.4k 0.5× 1.8k 0.5× 169 0.3× 920 1.9× 55 7.9k
Pierre M. Laduron Belgium 43 5.5k 0.7× 4.9k 0.7× 1.1k 0.3× 150 0.3× 554 1.2× 177 8.3k
Gavril W. Pasternak United States 79 14.2k 1.7× 12.3k 1.8× 7.1k 2.0× 904 1.8× 932 2.0× 331 19.8k
A. Pletscher Switzerland 52 4.0k 0.5× 3.4k 0.5× 1.3k 0.4× 277 0.5× 1.0k 2.2× 309 9.5k
R.J. Naylor United Kingdom 51 4.7k 0.6× 2.8k 0.4× 1.0k 0.3× 230 0.4× 924 1.9× 174 8.1k
Richard B. Rothman United States 70 12.6k 1.5× 8.9k 1.3× 2.1k 0.6× 733 1.4× 2.3k 4.8× 387 17.5k
Flavio Moroni Italy 57 4.3k 0.5× 4.2k 0.6× 1.2k 0.3× 212 0.4× 571 1.2× 232 10.5k

Countries citing papers authored by A.E. Takemori

Since Specialization
Citations

This map shows the geographic impact of A.E. Takemori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.E. Takemori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.E. Takemori more than expected).

Fields of papers citing papers by A.E. Takemori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.E. Takemori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.E. Takemori. The network helps show where A.E. Takemori may publish in the future.

Co-authorship network of co-authors of A.E. Takemori

This figure shows the co-authorship network connecting the top 25 collaborators of A.E. Takemori. A scholar is included among the top collaborators of A.E. Takemori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.E. Takemori. A.E. Takemori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Porreca, Frank, Henry I. Mosberg, K J Chang, et al.. (1993). Pharmacology of multiple opioid delta receptors. 430–436. 1 indexed citations
3.
Miyamoto, Yoshiyuki & A.E. Takemori. (1993). Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice. Life Sciences. 52(13). 1129–1134. 5 indexed citations
4.
5.
Horan, Peter J., Kenneth D. Wild, Wieslaw Kazmierski, et al.. (1993). Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action. European Journal of Pharmacology. 233(1). 53–62. 11 indexed citations
6.
Miyamoto, Yoshiyuki & A.E. Takemori. (1993). Relative involvement of supraspinal and spinal μ opioid receptors in morphine dependence in mice. Life Sciences. 52(12). 1039–1044. 14 indexed citations
7.
Porreca, Frank, A.E. Takemori, Marjia Sultana, et al.. (1992). Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 147–152. 91 indexed citations
8.
Song, Zhijing & A.E. Takemori. (1991). Involvement of spinal kappa opiod receptors in the antagonistic effect of dynorphins on morphine antinociception. Life Sciences. 48(15). 1447–1453. 22 indexed citations
9.
Sofuoglu, Mehmet, Philip S. Portoghese, & A.E. Takemori. (1991). Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypes. Life Sciences. 49(19). PL153–PL156. 40 indexed citations
10.
Takemori, A.E., et al.. (1990). Long-acting agonist and antagonist activities of naltrexamine bivalent ligands in mice. European Journal of Pharmacology. 186(2-3). 285–288. 9 indexed citations
11.
Portoghese, P. S., Marjia Sultana, & A.E. Takemori. (1990). Design of peptidomimetic .delta. opioid receptor antagonists using the message-address concept. Journal of Medicinal Chemistry. 33(6). 1714–1720. 226 indexed citations
12.
Ho, Begonia Y. & A.E. Takemori. (1990). Attenuation of the antinociceptive action of the selective κ-opioid receptor agonist, U-50,488H by ICS-205-930. European Journal of Pharmacology. 178(3). 371–373. 17 indexed citations
13.
Takemori, A.E. & Philip S. Portoghese. (1989). The use of μ opioid receptors in the mouse vas deferens for the study of opiate tolerance. European Journal of Pharmacology. 174(2-3). 267–271. 2 indexed citations
14.
Ho, Begonia Y. & A.E. Takemori. (1989). Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.. Journal of Pharmacology and Experimental Therapeutics. 250(2). 508–514. 59 indexed citations
15.
Portoghese, Philip S., Hiroshi Nagase, & A.E. Takemori. (1988). Stereochemical studies on medicinal agents. 31. Only one pharmacophore is required for the .kappa. opioid antagonist selectivity of norbinaltorphimine. Journal of Medicinal Chemistry. 31(7). 1344–1347. 40 indexed citations
16.
Portoghese, Philip S., Hiroshi Nagase, A. W. Lipkowski, Dennis L. Larson, & A.E. Takemori. (1988). Binaltorphimine-related bivalent ligands and their .kappa. opioid receptor antagonist selectivity. Journal of Medicinal Chemistry. 31(4). 836–841. 123 indexed citations
17.
Faden, Alan I., A.E. Takemori, & P. S. Portoghese. (1987). κ-Selective Opiate Antagonist Nor-Binaltorphimine Improves Outcome After Traumatic Spinal Cord Injury in Rats. PubMed. 4(4). 227–234. 37 indexed citations
18.
Ahlijanian, Michael K. & A.E. Takemori. (1986). Effects of caffeine and 8-phenyltheophylline on the actions of purines and opiates in the guinea-pig ileum.. Journal of Pharmacology and Experimental Therapeutics. 236(1). 171–176. 8 indexed citations
19.
Aceto, Mario D., et al.. (1984). β-Funaltrexamine (β-FNA) and morphine dependence. Federation Proceedings. 43(3). 2 indexed citations
20.
Takemori, A.E., et al.. (1976). Studies on the narcotic receptor in the guinea-pig ileum.. Journal of Pharmacology and Experimental Therapeutics. 199(1). 117–123. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026